|
1
|
Bray F, Ferlay J, Soerjomataram I, Siegel
RL, Torre LA and Jemal A: Global cancer statistics 2018: GLOBOCAN
estimates of incidence and mortality worldwide for 36 cancers in
185 countries. CA Cancer J Clin. 68:394–424. 2018.
|
|
2
|
Zhou C: Lung cancer molecular epidemiology
in China: Recent trends. Transl Lung Cancer Res. 3:270–279.
2014.
|
|
3
|
Chen Z, Fillmore CM, Hammerman PS, Kim CF
and Wong KK: Non-small-cell lung cancers: a heterogeneous set of
diseases. Nat Rev Cancer. 14:535–546. 2014.
|
|
4
|
Li Q, Liu M, Ma F, Luo Y, Cai R, Wang L,
Xu N and Xu B: Circulating miR-19a and miR-205 in serum may predict
the sensitivity of luminal A subtype of breast cancer patients to
neoadjuvant chemotherapy with epirubicin plus paclitaxel. PLoS One.
9:e1048702014.
|
|
5
|
Bach PB, Mirkin JN, Oliver TK, Azzoli CG,
Berry DA, Brawley OW, Byers T, Colditz GA, Gould MK, Jett JR, et
al: Benefits and harms of CT screening for lung cancer: a
systematic review. JAMA. 307:2418–2429. 2012.
|
|
6
|
Saghir Z, Dirksen A, Ashraf H, Bach KS,
Brodersen J, Clementsen PF, Døssing M, Hansen H, Kofoed KF, Larsen
KR, et al: Lung cancer screening with low dose CT requires careful
consideration. Ugeskr Laeger. 176:pii: V061403412014.In Danish.
|
|
7
|
Holdenrieder S, Wehnl B, Hettwer K, Simon
K, Uhlig S and Dayyani F: Carcinoembryonic antigen and
cytokeratin-19 fragments for assessment of therapy response in
non-small cell lung cancer: A systematic review and meta-analysis.
Br J Cancer. 116:1037–1045. 2017.
|
|
8
|
Okamura K, Takayama K, Izumi M, Harada T,
Furuyama K and Nakanishi Y: Diagnostic value of CEA and CYFRA 21-1
tumor markers in primary lung cancer. Lung cancer. 80:45–49.
2013.
|
|
9
|
Chen F, Wang XY, Han XH, Wang H and Qi J:
Diagnostic value of Cyfra21-1, SCC and CEA for differentiation of
early-stage NSCLC from benign lung disease. Int J Clin Exp Med.
8:11295–11300. 2015.
|
|
10
|
Reck M and Rabe KF: Precision Diagnosis
and Treatment for Advanced Non-Small-Cell Lung Cancer. N Engl J
Med. 377:849–861. 2017.
|
|
11
|
Zaborowski MP, Balaj L, Breakefield XO and
Lai CP: Extracellular Vesicles: Composition, Biological Relevance,
and Methods of Study. Bioscience. 65:783–797. 2015.
|
|
12
|
Vlassov AV, Magdaleno S, Setterquist R and
Conrad R: Exosomes: current knowledge of their composition,
biological functions, and diagnostic and therapeutic potentials.
Biochim Biophys Acta. 1820:940–948. 2012.
|
|
13
|
Trinchieri G: Cancer and inflammation: an
old intuition with rapidly evolving new concepts. Annu Rev Immunol.
30:677–706. 2012.
|
|
14
|
Pereira ER, Jones D, Jung K and Padera TP:
The lymph node microenvironment and its role in the progression of
metastatic cancer. Semin Cell Dev Biol. 38:98–105. 2015.
|
|
15
|
O’Loghlen A: Role for extracellular
vesicles in the tumour micro-environment. Philos Trans R Soc Lond B
Biol Sci. 373:3732018.
|
|
16
|
Wang Y, Yi J, Chen X, Zhang Y, Xu M and
Yang Z: The regulation of cancer cell migration by lung cancer
cell-derived exosomes through TGF-β and IL-10. Oncol Lett.
11:1527–1530. 2016.
|
|
17
|
Tang Y, Cui Y, Li Z, Jiao Z, Zhang Y, He
Y, Chen G, Zhou Q, Wang W, Zhou X, et al: Radiation-induced
miR-208a increases the proliferation and radioresistance by
targeting p21 in human lung cancer cells. J Exp Clin Cancer Res.
35:72016.
|
|
18
|
Lewis BP, Burge CB and Bartel DP:
Conserved seed pairing, often flanked by adenosines, indicates that
thousands of human genes are microRNA targets. Cell. 120:15–20.
2005.
|
|
19
|
Ma J and Li X: MicroRNAs are involved in
the toxicity of microcystins. Toxin Rev. 36:112017.
|
|
20
|
Ma J, Li Y, Yao L and Li X: Analysis of
MicroRNA Expression Profiling Involved in MC-LR-Induced
Cytotoxicity by High-Throughput Sequencing. Toxins (Basel).
9:92017.
|
|
21
|
Zhao Y, Xie P and Fan H: Genomic profiling
of microRNAs and proteomics reveals an early molecular alteration
associated with tumorigenesis induced by MC-LR in mice. Environ Sci
Technol. 46:34–41. 2012.
|
|
22
|
Maes OC, Chertkow HM, Wang E and Schipper
HM: MicroRNA: Implications for Alzheimer Disease and other Human
CNS Disorders. Curr Genomics. 10:154–168. 2009.
|
|
23
|
Xu J, Li Y, Wang F, Wang X, Cheng B, Ye F,
Xie X, Zhou C and Lu W: Suppressed miR-424 expression via
upregulation of target gene Chk1 contributes to the progression of
cervical cancer. Oncogene. 32:976–987. 2013.
|
|
24
|
Farazi TA, Hoell JI, Morozov P and Tuschl
T: MicroRNAs in human cancer. Adv Exp Med Biol. 774:1–20. 2013.
|
|
25
|
Detterbeck FC, Boffa DJ, Kim AW and Tanoue
LT: The Eighth Edition Lung Cancer Stage Classification. Chest.
151:193–203. 2017.
|
|
26
|
Coglitore D, Edwardson SP, Macko P,
Patterson EA and Whelan M: Transition from fractional to classical
Stokes-Einstein behaviour in simple fluids. R Soc Open Sci.
4:1705072017.
|
|
27
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2-ΔΔCT method. Methods. 25:402–408. 2001.
|
|
28
|
Raposo G and Stoorvogel W: Extracellular
vesicles: Exosomes, microvesicles, and friends. J Cell Biol.
200:373–383. 2013.
|
|
29
|
Okamura S, Arakawa H, Tanaka T, Nakanishi
H, Ng CC, Taya Y, Monden M and Nakamura Y: p53DINP1, a
p53-inducible gene, regulates p53-dependent apoptosis. Mol Cell.
8:85–94. 2001.
|
|
30
|
Yamashita S, Chujo M, Miyawaki M, Tokuishi
K, Anami K, Yamamoto S and Kawahara K: Combination of p53AIP1 and
survivin expression is a powerful prognostic marker in non-small
cell lung cancer. J Exp Clin Cancer Res. 28:222009.
|
|
31
|
Yamashita SI, Masuda Y, Yoshida N,
Matsuzaki H, Kurizaki T, Haga Y, Ikei S, Miyawaki M, Kawano Y,
Chujyo M and Kawahara K: p53AIP1 expression can be a prognostic
marker in non-small cell lung cancer. Clin Oncol (R Coll Radiol).
20:148–151. 2008.
|
|
32
|
Verma M, Lam TK, Hebert E and Divi RL:
Extracellular vesicles: Potential applications in cancer diagnosis,
prognosis, and epidemiology. BMC Clin Pathol. 15:62015.
|
|
33
|
Liu S, Zhan Y, Luo J, Feng J, Lu J, Zheng
H, Wen Q and Fan S: Roles of exosomes in the carcinogenesis and
clinical therapy of non-small cell lung cancer. Biomed
Pharmacother. 111:338–346. 2018.
|
|
34
|
Bonjoch L, Gironella M, Iovanna JL and
Closa D: REG3β modifies cell tumor function by impairing
extracellular vesicle uptake. Sci Rep. 7:31432017.
|
|
35
|
Mrowczynski OD, Madhankumar AB, Slagle
Webb B, Lee SY, Zacharia BE and Connor JR: HFE genotype affects
exosome phenotype in cancer. Biochim Biophys Acta Gen Subj.
1861:1921–1928. 2017.
|
|
36
|
Chen X, Ba Y, Ma L, Cai X, Yin Y, Wang K,
Guo J, Zhang Y, Chen J, Guo X, et al: Characterization of microRNAs
in serum: a novel class of biomarkers for diagnosis of cancer and
other diseases. Cell Res. 18:997–1006. 2008.
|
|
37
|
Lin Q, Mao W, Shu Y, Lin F, Liu S, Shen H,
Gao W, Li S and Shen D: A cluster of specified microRNAs in
peripheral blood as biomarkers for metastatic non-small-cell lung
cancer by stem-loop RT-PCR. J Cancer Res Clin Oncol. 138:85–93.
2012.
|
|
38
|
Wang ZX, Bian HB, Wang JR, Cheng ZX, Wang
KM and De W: Prognostic significance of serum miRNA-21 expression
in human non-small cell lung cancer. J Surg Oncol. 104:847–851.
2011.
|
|
39
|
Silva J, Garcia V, Zaballos A, Provencio
M, Lombardía L, Almonacid L, García JM, Domínguez G, Peña C, Diaz
R, et al: Vesicle-related microRNAs in plasma of nonsmall cell lung
cancer patients and correlation with survival. Eur Respir J.
37:617–623. 2011.
|
|
40
|
Kozomara A and Griffiths-Jones S: miRBase:
Annotating high confidence microRNAs using deep sequencing data.
Nucleic Acids Res. 42(D1): D68–D73. 2014.
|
|
41
|
Chen S, Sun KX, Liu BL, Zong ZH and Zhao
Y: MicroRNA-505 functions as a tumor suppressor in endometrial
cancer by targeting TGF-α. Mol Cancer. 15:112016.
|
|
42
|
Liu YJ, Li W, Chang F, Liu JN, Lin JX and
Chen DX: MicroRNA-505 is downregulated in human osteosarcoma and
regulates cell proliferation, migration and invasion. Oncol Rep.
39:491–500. 2018.
|
|
43
|
Lu L, Qiu C, Li D, Bai G, Liang J and Yang
Q: MicroRNA-505 suppresses proliferation and invasion in hepatoma
cells by directly targeting high-mobility group box 1. Life Sci.
157:12–18. 2016.
|
|
44
|
Chen T, Ren H, Thakur A, Yang T, Li Y,
Zhang S, Wang T and Chen M: miR-382 inhibits tumor progression by
targeting SETD8 in non-small cell lung cancer. Biomed Pharmacother.
86:248–253. 2017.
|
|
45
|
Zhou X, Wen W, Shan X, Zhu W, Xu J, Guo R,
Cheng W, Wang F, Qi LW, Chen Y, et al: A six-microRNA panel in
plasma was identified as a potential biomarker for lung
adenocarcinoma diagnosis. Oncotarget. 8:6513–6525. 2017.
|
|
46
|
Feng M, Zhao J, Wang L and Liu J:
Upregulated Expression of Serum Exosomal microRNAs as Diagnostic
Biomarkers of Lung Adenocarcinoma. Ann Clin Lab Sci. 48:712–718.
2018.
|
|
47
|
Maemura K, Watanabe K, Ando T, Hiyama N,
Sakatani T, Amano Y, Kage H, Nakajima J, Yatomi Y, Nagase T, et al:
Altered editing level of microRNAs is a potential biomarker in lung
adenocarcinoma. Cancer Sci. 109:3326–3335. 2018.
|
